Solaris Biotech

Delivering Scalable Biotech Solutions for Bioprocesses

Food and Beverages Tech Review

Follow Solaris Biotech on :

Matteo Brognoli, Co-Founder of Solaris Italy, Solaris BiotechMatteo Brognoli, Co-Founder of Solaris Italy
Enjoying meat that is not from an animal is a modern reality. With conventional agriculture causing adverse effects on climate, food chain, and animal welfare, alternative protein consumption is a step towards a sustainable future. Cellular agriculture companies are innovating solutions to traditional animal-based foods and ingredients by producing clean meat from animal muscle cells. However, with increasing customer demand, these companies face a major challenge in the form of scalability—growing a range of different cell types often requires customizable and scalable food fermentors or bioreactors.

Enter Solaris Biotech, a leading manufacturer of bioprocessing equipment. With exceptional prowess and experience in tailoring products and capabilities for customer demands, the company is perfectly positioned to supply the equipment necessary for innovation. Solaris specializes in bioreactors and fermenters that generate the optimal environment for cell cultivation, algae growth and microbial fermentation. Using intuitive automation and software, these systems support the full scope of process development from benchtop bioreactors to pilot to production scale. The flexible laboratory scale equipment ranges from 120 ml to 20L, and the customizable, cGMP certifiable industrial equipment ranges from pilot-scale systems of 20-300L up to 50000L. These systems can be integrated with ancillary bioprocess equipment and customizable tangential flow filtration(TFF) systems. Solaris also assists its clients in the design and manufacturing of complete integrated turnkey process plants. “Our equipment and software enable customers to develop processes in a lab and effectively scale up for production,” says Tim Erisman, vice president-USA at Solaris Biotech. Founded in 2002, Solaris has since grown exponentially and meticulously caters customer needs in diverse industries such as pharmaceutical, biotechnology, and food and beverages.

While the company’s equipment is ideal for pharmaceutical applications, the alternative protein market also uses similar technologies for cell culture, increasing demand in the sector. A preferred choice for many of the largest food and beverage manufacturers in the U.S, Solaris supplies vessels to other branches, including fermented drinks, wines, meat preservatives, and flavors. Erisman also mentions a broader demand from universities for research and companies adding bio-processed food to their product mix to satisfy their customers. “Our equipment is integral to the food production in the U.S,” quips Erisman.

At the core of these advanced and accessible solutions is the powerful software Leonardo 3.0 with the same interface at every process scale—from benchtop units to pilot-industrial scales. Having started by producing large scale equipment, Solaris understands the requirements for both spectrums and enables the platform to integrate with any system. Being intuitive and easy to use, the interface communicates with one or more Siemens PLCs to control, record, and display all process parameters in real-time during cultivation. This technically collaborative approach enables improved efficiency in optimization, communication, and scale up.

Solaris assists its clients in the design of process equipment through the design of feasibility studies. This helps identify costs related to realizing projects and making crucial early decisions when starting a new biotech project. The company also lends support in basic engineering for process plant design. In the case of the benchtop series, Solaris offers an exclusive opportunity to test the equipment's performance before purchase. Clients can also run their experiments at any scale and work on process development and optimization at Solaris Training Centre, with highly qualified personnel assisting them step by step during the process.

  • Our equipment and software enable customers to develop processes in a lab and effectively scale up for production


Highlighting the solutions' efficiency, Erisman cites an instance where Solaris helped a preservative company scale its production to meet the product demand during the COVID-19 pandemic. The equipment installed by Solaris enabled mass capacity and improved production processes, bringing in quadrupled sales. In another instance, Solaris helped a fermentation company with an anaerobic enzymatic process conducted at a fixed temperature. The client was inexperienced in this process and didn't know the right parameters for cell growth. While the previous system allowed a 30-degree swing in temperature parameter, the Solaris system is accurate down to a 10th of a degree variation. Solaris equipment showed a significant improvement in growth rate at a different temperature, thus improving the process dramatically. This accelerated production, and the client was able to run one system for half the time instead of eight systems, increasing the capacity, efficiency, and yield of the process.

Solaris today is an integral part of a revolution that is changing the way humanity consumes food. “The future will have seafood not from the sea, beef not from cows, and pork not from pigs. Our customers are working towards this change and we strive to help them take a step forward every day through our scalable solutions,” concludes Erisman.

Share this Article:

Company
Solaris Biotech

Management
Matteo Brognoli, Co-Founder of Solaris Italy

Description
Solaris is a manufacturer of bioprocessing equipment specializing in bioreactors/fermentors, TFF systems, process tanks, CIP/SIP systems, ancillary equipment and much more. Products and capabilities are tailored for the demands associated with the biotechnology, pharmaceutical, food, beverage and dairy industries. Solaris’s expertise in many bioprocess disciplines gives unique capabilities associated with standalone systems as well as the ability to integrate process steps into complete turnkey plants

  • Solaris Biotech News

Solaris Biotech and Extracellular cooperate for a sustainable food industry

Solaris Biotech and Extracellular, active in the field of cultured meat and sustainable food technologies, have started a new and innovative collaboration.
MANTOVA - Extracellular uses Solaris Biotech cultivators to develop production processes for the cultured meat industry. In fact, it offers a research and development service for third parties, providing its cultivators and know-how for the time it takes to develop the production process that will then be applied by the client industry.
Extracellular is actively engaged in addressing the increasing interest in alternative protein sources to tackle the environmental and ethical challenges linked to conventional animal farming.
Lab-grown meat, or cultured meat, entails the creation of food products directly from animal cells within a biotechnologically regulated setting. This innovative approach represents a sustainable substitute for traditional animal breeding and slaughter practices.
Located in Bristol, UK, this company is contributing to the promotion of a more sustainable and ethical food system by potentially diminishing the environmental impact associated with meat production.
Extracellular employs compact and versatile cultivators from the "ONE" model family to showcase the suitability of both microbial and mammalian systems for cultured meat applications. Cultivators are apparatuses used to foster the growth of microorganisms or cells within a precisely controlled environment. They facilitate various fermentation processes, including the cultivation of bacteria, yeasts, or other cell cultures, all of which can be conducted under controlled conditions by researchers and biotechnologists.
Katrien Verbrugge, Sales Director EMEA of Solaris Biotech: "The Solaris ONE cultivators allow Extracellular to test cell performance on a small scale before moving on to larger systems. The Extracellular team is using the Solaris lab equipment to test agitation, temperature, pH, dO2 and feeding strategies."
Kiren Baines Co-Founder & CSO of Extracellular: "Our commitment is to combine expertise, resources and cutting-edge technology to accelerate research, development and commercialisation efforts. The ultimate goal is to bring increasingly innovative products and solutions to the market. Solaris' ONE cultivator, with its Wi-Fi connection and simple web interface, is very useful to easily set up and design processes for our customers."
Will Milligan, Co-Founder & CEO of Extracellular, said: “We found it to be a great system, with great control software.”

Top